ECHOSTAR CORP-A (SATS)

US2787681061 - Common Stock

22.75  +0.14 (+0.62%)

After market: 22.75 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SATS. SATS was compared to 92 industry peers in the Media industry. SATS may be in some trouble as it scores bad on both profitability and health. SATS does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

In the past year SATS has reported negative net income.
In the past year SATS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SATS reported negative net income in multiple years.
In the past 5 years SATS always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of SATS (-3.82%) is comparable to the rest of the industry.
SATS has a Return On Equity (-11.32%) which is comparable to the rest of the industry.
SATS has a worse Return On Invested Capital (0.21%) than 68.13% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SATS is significantly below the industry average of 6.95%.
Industry RankSector Rank
ROA -3.82%
ROE -11.32%
ROIC 0.21%
ROA(3y)0.36%
ROA(5y)-0.07%
ROE(3y)-0.44%
ROE(5y)-0.84%
ROIC(3y)1.94%
ROIC(5y)1.61%

1.3 Margins

With a Operating Margin value of 0.52%, SATS is not doing good in the industry: 67.03% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of SATS has declined.
The Gross Margin of SATS (26.87%) is worse than 70.33% of its industry peers.
SATS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.52%
PM (TTM) N/A
GM 26.87%
OM growth 3Y-22.28%
OM growth 5Y-13.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.06%
GM growth 5Y-12.47%

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SATS is destroying value.
SATS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SATS has been increased compared to 5 years ago.
Compared to 1 year ago, SATS has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that SATS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.81, SATS perfoms like the industry average, outperforming 49.45% of the companies in the same industry.
A Debt/Equity ratio of 1.11 is on the high side and indicates that SATS has dependencies on debt financing.
SATS has a worse Debt to Equity ratio (1.11) than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACC0.02
WACC8.77%

2.3 Liquidity

SATS has a Current Ratio of 0.67. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SATS (0.67) is worse than 86.81% of its industry peers.
SATS has a Quick Ratio of 0.67. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
SATS's Quick ratio of 0.61 is on the low side compared to the rest of the industry. SATS is outperformed by 86.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.61

3

3. Growth

3.1 Past

SATS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -280.85%.
The Revenue has grown by 1426.74% in the past year. This is a very strong growth!
SATS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.38% yearly.
EPS 1Y (TTM)-280.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)1426.74%
Revenue growth 3Y108.11%
Revenue growth 5Y57.38%
Sales Q2Q%841.96%

3.2 Future

Based on estimates for the next years, SATS will show a very negative growth in Earnings Per Share. The EPS will decrease by -150.76% on average per year.
SATS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.99% yearly.
EPS Next Y-3558.6%
EPS Next 2Y-563.82%
EPS Next 3Y-365.08%
EPS Next 5Y-150.76%
Revenue Next Year-0.54%
Revenue Next 2Y-2.21%
Revenue Next 3Y-3.32%
Revenue Next 5Y-9.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

SATS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SATS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SATS.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.17

4.3 Compensation for Growth

SATS's earnings are expected to decrease with -365.08% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-563.82%
EPS Next 3Y-365.08%

0

5. Dividend

5.1 Amount

No dividends for SATS!.
Industry RankSector Rank
Dividend Yield N/A

ECHOSTAR CORP-A

NASDAQ:SATS (12/20/2024, 8:00:01 PM)

After market: 22.75 0 (0%)

22.75

+0.14 (+0.62%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners41.16%
Inst Owner Change-3.75%
Ins Owners8.58%
Ins Owner Change0%
Market Cap6.18B
Analysts75
Price Target23.05 (1.32%)
Short Float %11.36%
Short Ratio8.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-113.27%
Min EPS beat(2)-197.05%
Max EPS beat(2)-29.49%
EPS beat(4)0
Avg EPS beat(4)-265.47%
Min EPS beat(4)-752.94%
Max EPS beat(4)-29.49%
EPS beat(8)4
Avg EPS beat(8)-83.89%
EPS beat(12)5
Avg EPS beat(12)-59.19%
EPS beat(16)9
Avg EPS beat(16)126.47%
Revenue beat(2)0
Avg Revenue beat(2)-2.55%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)-2.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.85%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)4.78%
Revenue beat(8)2
Avg Revenue beat(8)-2.87%
Revenue beat(12)4
Avg Revenue beat(12)-1.96%
Revenue beat(16)8
Avg Revenue beat(16)-1.2%
PT rev (1m)0.44%
PT rev (3m)12.6%
EPS NQ rev (1m)-23.71%
EPS NQ rev (3m)-23.71%
EPS NY rev (1m)-7.91%
EPS NY rev (3m)16.62%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.12%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF 1.85
P/B 0.32
P/tB 0.32
EV/EBITDA 10.17
EPS(TTM)-2.55
EYN/A
EPS(NY)-2.2
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)12.28
OCFY53.99%
SpS101.41
BVpS71.52
TBVpS71.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.82%
ROE -11.32%
ROCE 0.29%
ROIC 0.21%
ROICexc 0.21%
ROICexgc 0.21%
OM 0.52%
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)0.36%
ROA(5y)-0.07%
ROE(3y)-0.44%
ROE(5y)-0.84%
ROIC(3y)1.94%
ROIC(5y)1.61%
ROICexc(3y)2.63%
ROICexc(5y)2.35%
ROICexgc(3y)3.09%
ROICexgc(5y)2.8%
ROCE(3y)2.72%
ROCE(5y)2.26%
ROICexcg growth 3Y-39.21%
ROICexcg growth 5Y-18.25%
ROICexc growth 3Y-34.39%
ROICexc growth 5Y-15.93%
OM growth 3Y-22.28%
OM growth 5Y-13.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.06%
GM growth 5Y-12.47%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA 7.43
Cap/Depr 147.83%
Cap/Sales 14.78%
Interest Coverage 0.06
Cash Conversion 115.1%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.61
Altman-Z 0.81
F-Score3
WACC8.77%
ROIC/WACC0.02
Cap/Depr(3y)122.18%
Cap/Depr(5y)106.75%
Cap/Sales(3y)19.82%
Cap/Sales(5y)21.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-280.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
EPS Next Y-3558.6%
EPS Next 2Y-563.82%
EPS Next 3Y-365.08%
EPS Next 5Y-150.76%
Revenue 1Y (TTM)1426.74%
Revenue growth 3Y108.11%
Revenue growth 5Y57.38%
Sales Q2Q%841.96%
Revenue Next Year-0.54%
Revenue Next 2Y-2.21%
Revenue Next 3Y-3.32%
Revenue Next 5Y-9.99%
EBIT growth 1Y-3.64%
EBIT growth 3Y61.74%
EBIT growth 5Y36.68%
EBIT Next Year257.29%
EBIT Next 3Y58.11%
EBIT Next 5Y17.09%
FCF growth 1Y-494.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y509.71%
OCF growth 3Y65.73%
OCF growth 5Y27.06%